381 related articles for article (PubMed ID: 24183231)
41. Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease.
Setyawan J; Mu F; Zichlin ML; Billmyer E; Downes N; Yang H; Azimi N; Strand V; Yarur A
Adv Ther; 2022 Jan; 39(1):738-753. PubMed ID: 34877631
[TBL] [Abstract][Full Text] [Related]
42. The risk of venous thromboembolism in women with inflammatory bowel disease during pregnancy and the postpartum period: A systematic review and meta-analysis.
Kim YH; Pfaller B; Marson A; Yim HW; Huang V; Ito S
Medicine (Baltimore); 2019 Sep; 98(38):e17309. PubMed ID: 31568016
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of venous thromboembolism and coagulation-fibrinolysis markers in Japanese patients with inflammatory bowel disease.
Sonoda K; Ikeda S; Mizuta Y; Miyahara Y; Kohno S
J Gastroenterol; 2004 Oct; 39(10):948-54. PubMed ID: 15549447
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients.
Sridhar AR; Parasa S; Navaneethan U; Crowell MD; Olden K
J Crohns Colitis; 2011 Aug; 5(4):287-94. PubMed ID: 21683298
[TBL] [Abstract][Full Text] [Related]
45. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
Oldenburg B; Fijnheer R; van der Griend R; vanBerge-Henegouwen GP; Koningsberger JC
Am J Gastroenterol; 2000 Oct; 95(10):2825-30. PubMed ID: 11051355
[TBL] [Abstract][Full Text] [Related]
46. Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study.
Kirchgesner J; Beaugerie L; Carrat F; Andersen NN; Jess T; Schwarzinger M;
Gut; 2018 Jul; 67(7):1261-1268. PubMed ID: 28647686
[TBL] [Abstract][Full Text] [Related]
47. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
48. Risk of venous thromboembolism in patients with inflammatory bowel disease.
Koutroumpakis EI; Tsiolakidou G; Koutroubakis IE
Semin Thromb Hemost; 2013 Jul; 39(5):461-8. PubMed ID: 23629820
[TBL] [Abstract][Full Text] [Related]
49. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
[TBL] [Abstract][Full Text] [Related]
50. Prevention and therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases: a report of three cases.
Włodarczyk M; Sobolewska A; Fichna J; Wiśniewska-Jarosińska M
Curr Drug Targets; 2015; 16(3):194-8. PubMed ID: 25382207
[TBL] [Abstract][Full Text] [Related]
51. The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile.
Bollen L; Vande Casteele N; Peeters M; Van Assche G; Ferrante M; Van Moerkercke W; Declerck P; Vermeire S; Gils A
Inflamm Bowel Dis; 2015 Nov; 21(11):2540-8. PubMed ID: 26313696
[TBL] [Abstract][Full Text] [Related]
52. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.
Gangireddy C; Rectenwald JR; Upchurch GR; Wakefield TW; Khuri S; Henderson WG; Henke PK
J Vasc Surg; 2007 Feb; 45(2):335-341; discussion 341-2. PubMed ID: 17264013
[TBL] [Abstract][Full Text] [Related]
53. Overview of venous thrombosis in inflammatory bowel disease.
Purnak T; Yuksel O
Inflamm Bowel Dis; 2015 May; 21(5):1195-203. PubMed ID: 25581828
[TBL] [Abstract][Full Text] [Related]
54. Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia.
Oldenburg B; Van Tuyl BA; van der Griend R; Fijnheer R; van Berge Henegouwen GP
Dig Dis Sci; 2005 Feb; 50(2):235-40. PubMed ID: 15745078
[TBL] [Abstract][Full Text] [Related]
55. Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis.
Mismetti P; Quenet S; Levine M; Merli G; Decousus H; Derobert E; Laporte S
Chest; 2005 Oct; 128(4):2203-10. PubMed ID: 16236875
[TBL] [Abstract][Full Text] [Related]
56. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology.
Cushman M; Tsai AW; White RH; Heckbert SR; Rosamond WD; Enright P; Folsom AR
Am J Med; 2004 Jul; 117(1):19-25. PubMed ID: 15210384
[TBL] [Abstract][Full Text] [Related]
57. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials.
Wein L; Wein S; Haas SJ; Shaw J; Krum H
Arch Intern Med; 2007 Jul; 167(14):1476-86. PubMed ID: 17646601
[TBL] [Abstract][Full Text] [Related]
58. [Thromboembolic complications in inflammatory bowel disease].
Suárez Crespo JF; Nogueras López F; de Teresa Galván FJ; de Sola Earle CM; González Galilea A; Pinel Julián LM; Ruiz-Cabello Jiménez M
Gastroenterol Hepatol; 1997 Apr; 20(4):180-3. PubMed ID: 9280611
[TBL] [Abstract][Full Text] [Related]
59. Overview of Link Between Inflammatory Bowel Disease and Cardiovascular Disease.
Nevulis MG; Baker C; Lebovics E; Frishman WH
Cardiol Rev; 2018; 26(6):287-293. PubMed ID: 30277903
[TBL] [Abstract][Full Text] [Related]
60. Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia.
Spina L; Saibeni S; Battaglioli T; Peyvandi F; de Franchis R; Vecchi M
Am J Gastroenterol; 2005 Sep; 100(9):2036-41. PubMed ID: 16128949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
